# OnCo record nct02205762 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02205762/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02205762", "NCT02205762" ;
  schema:name "LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis"@en ;
  schema:description "A phase 2/3 trial of Prednisone, Vinblastine, Mercaptopurine, Methotrexate, Cytarabine, Cladribine and Human normal immunoglobulin in Langerhans cell histiocytosis, run by North American Consortium for Histiocytosis, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02205762/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02205762> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/langerhans-cell-histiocytosis/> ;
  onco:drugs <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/mercaptopurine/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/cladribine/>, <https://onco.cc/drugs/human-normal-immunoglobulin/> .